Open AccessP527: PHASE 1 TRIAL OF PEGCRISANTASPASE IN COMBINATION WITH VENETOCLAX IN ADULTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA (R/R AML) ‐ SAFETY, EFFICACY AND PK/PD IN THE FIRST TWO COHORTS
Author(s) -
Liu Y.,
Bah O. M.,
Bollino D.,
Caprinolo K.,
Zarrabi J.,
Philip S.,
Lapidus R. G.,
Strovel E. T.,
Singh Z. N.,
Kallen M. E.,
Ning Y.,
Koka R.,
Niyongere S.,
Duong V. H.,
Baer M. R.,
Graveno M.,
Emadi A.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844996.76777.9b
Subject(s) - venetoclax , ven , medicine , regimen , bristol myers , pharmacodynamics , adverse effect , oncology , pharmacokinetics , refractory (planetary science) , pharmacology , leukemia , biology , chronic lymphocytic leukemia , computer security , computer science , astrobiology